Phase One Services: Dr. Elizabeth Allen
In 2008 TUFTS reported that it costs over $1 billion to develop a new bio pharmaceutical product. Half of this investment occurs in the later stages of testing. Thankfully at Quintiles, we provide accurate and correct Phase I and IIa data quickly. We can help you make smart, safe decisions earlier to avoid repeating costly studies later.
